help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walfish, P. G.
Right arrow Articles by Rosen, I. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walfish, P. G.
Right arrow Articles by Rosen, I. B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*THYROGLOBULIN

Journal of Clinical Endocrinology & Metabolism, Vol 75, 224-227, Copyright © 1992 by Endocrine Society

ARTICLES

Postparathyroidectomy transient thyrotoxicosis

PG Walfish, D Caplan and IB Rosen
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.

Three patients are described who had spontaneously resolving transient thyrotoxicosis after resection of a parathyroid adenoma without thyroidectomy or an apparent thyroid abnormality before or during surgery. All had documented thyrotoxicosis that developed within 2 weeks after surgery, which was clinically symptomatic in two of three patients. The thyrotoxicosis was associated with subnormal radioactive iodine thyroid uptake when performed in the two symptomatic patients and was consistent with a postsurgical inflammatory etiology secondary to thyroid gland trauma during parathyroidectomy. In all patients, the clinical and biochemical evidence of thyrotoxicosis resolved within 2 months. Antithyroglobulin and antimicrosomal antibodies were not detected in the two patients who had a complete recovery 3 months after surgery. However, in the patient who had autoimmune thyroiditis, hyperthyroidism due to Graves' disease subsequently developed 19 months after parathyroidectomy and was associated with increasing titers of antithyroglobulin and antimicrosomal thyroidal autoantibodies. From these observations, we conclude that 1) spontaneously resolving transient thyrotoxicosis of varying severity may occur in some patients after parathyroidectomy, which could be secondary to intraoperative thyroid gland manipulation, and 2) while the occurrence of subsequent Graves' hyperthyroidism in a patient with underlying autoimmune thyroiditis may have been a coincidence, this observation also raises the possibility that thyroidal autoantigen released during parathyroidectomy may trigger the reactivation of autoimmune thyroid disease in a predisposed subject.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
N. Caraccio, A. Dardano, F. Manfredonia, L. Manca, L. Pasquali, A. Iudice, L. Murri, E. Ferrannini, and F. Monzani
Long-Term Follow-Up of 106 Multiple Sclerosis Patients Undergoing Interferon-{beta} 1a or 1b Therapy: Predictive Factors of Thyroid Disease Development and Duration
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4133 - 4137.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. Nygaard, J. H. Knudsen, L. Hegedus, A. V. C. Scient, and J. E. Molholm Hansen
Thyrotropin Receptor Antibodies and Graves' Disease, a Side-Effect of 131I Treatment in Patients with Nontoxic Goiter
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2926 - 2930.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society